部分代表性的论文：

Ø   Dong Y,†  Wang H, †Li GD (Co-first author),^† Wang CY, Han LQ, Wan ZM, Yan J, Zhang QX, Zhang M, Ke PF, Li HB, Wu XZ,*  Hang XZ,* Zhang Pengwei*, . (2024) Comprehensive Identification and Comparative Analysis of Protein-unbound Amadori Products in Powdered Infant Formulas: Integrating Untargeted and Targeted Metabolomics with LC-Q-Orbitrap-MS/MS. LWT Food Science and Technology, In press, IF = 6.0 

Ø   Chen SM,†  Shen CX, † Li WY,† Fan Y, Yang DH, Wang YT,  Feng RB,* LI GD(Co-corresponding author)*, Zhong ZF*, . (2024) Recent Advances in Bioactivity-Guided Drug Screening Strategies for Pre-Clinical and Clinical Drug Discovery. TrAC Trends in Analytical Chemistry, In press, IF = 11.8 

Ø   Zhong YX,†  Zhang XY, † Feng RB,† Fan Y, Zhang Z*,  Zhang QW, Wan JB, Wang YT*, YU H,* LI GD(Co-corresponding author )*. (2024) OGG1: An Emerging Multifunctional Therapeutic Target for the Treatment of Diseases Caused by Oxidative DNA Damage. Medicinal Research Reviews, 44(6):2825-2848, IF = 13.3 Front cover 

Ø   Fan Y,† Feng RB,†  Zhang XY, Wang ZL, Xiong F, Zhang SH, Zhong ZF, Yu H, Zhang QW, Zhang Z*, Wang YT*, LI GD(Co-corresponding author )*. (2024) Encoding and display technologies for combinatorial libraries in drug discovery: The coming of age from biology to therapy. Acta Pharmaceutica Sinica B, 14(8): 3362-3384, IF = 14.5

Ø   Feng RB,† Fan Y,† Zhang XY,† Chen LM, Zhong ZF, Wang YT*, YU H*, Zhang QW*, LI GD(Co-corresponding author )*. (2024) A Biomimetic Multifunctional Nanoframework for Symptom Relief and Restorative Treatment of Acute Liver Failure. ACS Nano, 18(7): 5951-5964, IF = 17.1 Supplementary Cover

Ø   Jin HC,^† Cui DX,^† Fan Y,^† Li GD (Co-corresponding author )*, Zhong ZF*, Wang YT*. (2023) Recent Advances in Bio-Affinity Strategies for Pre-Clinical and Clinical Drug Discovery: Screening Natural Products, Small Molecules, and Antibodies. Drug Discov Today, DOI: 10.1016/j.drudis.2024.103885. (In press), IF = 7.4 

Ø   Chan KI, Zhang SY,^† Li GD (Co-first author),^† Xu YD, Cui L, Wang YT, Su HX*, Tan W* and Zhong ZF*. (2023) MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products. Aging Dis, DOI: 10.14336/AD.2023.0520. IF = 7.4

Ø   Li GD,^† Huang Q,^† Wong KW Vincent*, Wang WH* and Leung CH*. (2023) Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment. Genes Dis, 2260-2262. IF = 6.8

Ø   Li GD,^† Ko CN,^† Wang ZK, Chen F, Wang WH*, Ma DL* and Leung CH*. (2023) Interference reduction isothermal nucleic acid amplification strategy for COVID-19 variant detection. Sens Actuators B Chem, 133006. IF = 8.4

Ø   Feng RB,^† Li GD (Co-first author),^† Ko CN,^† Zhang Z, Wan JB* and Zhang QW*. (2023) Long-lived second near-infrared luminescent probes: an emerging role in time-resolved luminescence bioimaging and biosensing. Small Struct, 2200131. IF = 15.9, Inside front cover (MaterialsViews新闻报道: https://mp.weixin.qq.com/s/1mmKgx3jGSfRcAOrBo8J7Q)

Ø   Li GD,^† Li D,^† Wu C,^† Li S, Chen F, Li P, Ko CN, Wang W, Lee SMY, Lin LG*, Ma DL* and Leung CH*. (2022) Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via histone methyltransferase SET7/9 inhibition. Exp. Mol. Med. 54(7), 988. IF = 12.8

Ø   Chen F,^† Li GD (Co-first author),^† Wu C,^† Wang L, Ko, CN, Ma DL,* Leung CH.* (2022) Interference reduction biosensing strategy for highly sensitive microRNA detection. Anal Chem. 94(10), 4513. IF = 7.4

Ø   Ø   Chen F,^† Li GD (Co-first author),^† Wu C,^† Wang WH, Ma DL,* Leung CH.* (2022) A Rapid and Label-Free DNA-based Interference Reduction Nucleic Acid Amplification Strategy for Viral RNA Detection. Biosens Bioelectron. 113829. IF = 12.6

Ø   Li GD,^† Liu H,^† Feng RB,^† Kand TS,^† Wang WH, Ko CN, Wong CY, Ye M, Ma DL*, Wan JB* and Leung CH*. (2021) A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury. Redox Biol, 102129. IF = 11.4

Ø   Li GD,^† Ko CN,^† Li D,^† Yang C,^† Wang WH, Yang GJ, C Di Primo, Wong KW, Xiang YZ, Lin LG*, Ma DL* and Leung CH*. (2021) A small molecule HIF-1α stabilizer that accelerates diabetic wound healing. Nat Commun 12, 3363. IF = 16.6 (BioArt 新闻报道：https://mp.weixin.qq.com/s/IwWt8ZpxYhao5A8z_oKZGg，澳门日报新闻报道：http://www.macaodaily.com/html/2021-06/16/content_1523554.htm 等) 

Ø   Li GD, Wu C, Ma DL*, and Leung CH*. (2021) Drug screening strategies using metal-based luminescent probes. Trends Analyt Chem, 116270.  IF = 13.1 (JCR ranking: 1/86 in chemistry and analytical)

Ø   Li GD^#, Boyle JW^#, Ko CN^#, Zeng W, Wong VKW, Wan JB, Chan PWH,* Ma DL,* Leung CH.* (2019) Aurone derivatives as Vps34 inhibitors that modulate autophagy. Acta Pharm Sin B 9, 537. IF = 14.5

Ø   Li GD^#, Stuart AH^#, Liu H^#, Kang TS^#, Nao SC^#, Zhao YC, Wu C, Jin JW, Zhang JT, Leung CH*, Chan PHC*, Ma DL*. (2020) A robust photoluminescence screening assay identifies uracil-DNA glycosylase inhibitors against prostate cancer. Chem Sci 11, 1750. IF = 8.4, Outside front cover 

Ø   Vellaisamy K,^† Li GD (Co-first author),^† Ko CN,^† Zhong HJ, Fatima S, Kwan HY, Wong CY, Kwong WJ,* Tan WH,* Leung CH,* Ma DL.* (2018) Cell imaging of dopamine receptor using agonist labeling iridium(III) complex. Chem Sci 9, 1119. IF = 8.4, (1% 高被引论文 2020年) Inside front cover 

Ø   Vellaisamy K,^† Li GD (Co-first author),^† Wang WH,^† Leung CH,* Ma DL.* (2018) A long-lived peptide-conjugated iridium(III) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2. Chem Sci 9, 8171. IF = 8.4, Front cover 

Ø   Chen F,^† Li GD (Co-first author),^† Liu H, Leung CH, Ma DL. (2020) G-quadruplex-based detection of glyphosate in complex biological systems by a time-resolved luminescent assay. Sensor Actuat B Chem 320,128393. IF = 8.4

Ø   Wang WH,^† Vellaisamy K,^† Li GD (Co-first author),^† Wu C, Ko CN, Leung CH,* Ma DL.* (2017) Development of a long-lived luminescence probe for visualizing β-galactosidase in ovarian carcinoma cells. Anal Chem 89, 11679. IF = 7.4

Ø   Ko CN, Li GD, Leung CH,* Ma DL.* (2019) Dual function luminescent transition metal complexes for cancer theranostics: the combination of diagnosis and therapy. Coord Chem Rev 381, 79. IF = 20.6